Myeloma and Related Diseases Registry (MRDR)

Register now to secure your spot at the MRDR Annual Breakfast Meeting at Blood 2025 in Perth, 27 October. We'd love to see you at this free hybrid event - just click on 'News' above and select the first item. All are welcome!

View our 2024 Annual Report Here

This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.

What is the registry?

Learn about how the registry works and the data we collect.
Benefits

Participation in the registry provides advantages for sites and patients.
About our projects

Find out about MRDR projects and how registry data is being used.
8317

Patients accrued

5757

Patients with multiple myeloma

60

Number of approved sites

773

M1000 Biobank participants

Latest news

MRDR Annual Breakfast Meeting 2025
13 Oct 2025

Register now for the MRDR Annual Breakfast Meeting at Blood 2025!

Read more
MRDR Events at Blood 2025
30 Sep 2025

Come find our presentations at Blood/ISBT 2025

Read more
New MRDR Publication
09 Sep 2025

An MRDR paper investigating treatment outcomes for multiple myeloma in elderly transplant ineligible patients has been published!

Read more
Rare Disease Day 2025
19 Feb 2025

Rare Disease Day is next week on Friday 28th February!

Read more

Participating organisations